{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:00:52Z","timestamp":1761919252041,"version":"3.37.0"},"reference-count":113,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2253,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1111\/j.1600-0404.2008.01146.x","type":"journal-article","created":{"date-parts":[[2009,6,5]],"date-time":"2009-06-05T06:54:40Z","timestamp":1244184880000},"page":"1-15","source":"Crossref","is-referenced-by-count":27,"title":["Neurological comorbidity and epilepsy: implications for treatment"],"prefix":"10.1155","volume":"120","author":[{"given":"G.","family":"Zaccara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0021-9681(70)90054-8","article-title":"The pre-therapeutic classification of comorbidity in chronic disease","volume":"23","author":"Feinstein","year":"1973","journal-title":"J Chronic Dis"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB2","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/j.1528-1167.2005.00344.x","article-title":"Somatic comorbidity of epilepsy in the general population in Canada","volume":"46","author":"Tellez-Zenteno","year":"2005","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1528-1157.1996.tb00547.x","article-title":"Concurrent illnesses in adults with childhood-onset epilepsy: a population-based 35-years follow up study","volume":"37","author":"Jalava","year":"1996","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB4","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.0013-9580.2004.17504.x","article-title":"The epidemiology of the comorbidity in epilepsy in the general population","volume":"45","author":"Gaitatzis","year":"2004","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB5","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jclinepi.2006.01.005","article-title":"Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study","volume":"59","author":"Nuyen","year":"2006","journal-title":"J Clin Epidemiol"},{"issue":"Suppl. 4","key":"10.1111\/j.1600-0404.2008.01146.x-BIB6","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1212\/WNL.67.12_suppl_4.S39","article-title":"Optimizing therapy of seizures in adult patients with psychiatric comorbidity","volume":"67","author":"Brodtkorb","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB7","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000247045.85646.c0","article-title":"Psychotropic effects of antiepileptic drugs","volume":"67","author":"Ettinger","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200822010-00003","article-title":"Antiepileptic drugs in non-epilepsy disorders. Relations between mechanisms of actions and clinical efficacy","volume":"22","author":"Johannessen Landmark","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota. 1935-1984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"issue":"Suppl. 4","key":"10.1111\/j.1600-0404.2008.01146.x-BIB10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.67.12_suppl_4.S3","article-title":"Optimizing therapy of seizures in stroke patients","volume":"67","author":"Ryvlin","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB11","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1528-1167.2007.01513.x","article-title":"Incidence of seizures in the acute phase of stroke: a population-based study","volume":"49","author":"Szaflarsky","year":"2008","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1528-1167.2005.57904.x","article-title":"Poststroke epilepsy: occurrence and predictors - a long-term prospective controlled study (Akershus Stroke Study)","volume":"46","author":"Lossius","year":"2005","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000072554","article-title":"European stroke initiative recommendations for stroke management: update 2003","volume":"16","author":"Hack","year":"2003","journal-title":"Cerebrovasc Dis"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.STR.30.4.905","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for health care professionals from a special writing group of the Stroke Council, American Health association","volume":"30","author":"Broderick","year":"1999","journal-title":"Stroke"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WNF.0b013e3180333069","article-title":"Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure","volume":"30","author":"Gilad","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB16","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1212\/01.WNL.0000038388.57824.B6","article-title":"Gabapentin in late-onset poststroke seizures","volume":"59","author":"Alvarez-Sabin","year":"2002","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1528-1157.2001.29000.x","article-title":"Does the cause of localization-related epilepsy influence the response to antiepileptic drug treatment?","volume":"42","author":"Stephen","year":"2001","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1111\/j.1600-0404.2008.01146.x-BIB18","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.eplepsyres.2005.07.016","article-title":"Epidemiological and medical aspects of epilepsy in the elderly","volume":"68","author":"Cloyd","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1684\/j.1950-6945.2004.tb00064.x","article-title":"Adverse motor effects induced by antiepileptic drugs","volume":"6","author":"Zaccara","year":"2004","journal-title":"Epileptic Disord"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB20","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1528-1167.2007.01041.x","article-title":"Idiosyncratic adverse reactions to antiepileptic rugs","volume":"48","author":"Zaccara","year":"2007","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB21","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/WNL.45.6.1155","article-title":"Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy","volume":"45","author":"Eir\u00eds","year":"1995","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/08830738060210011301","article-title":"Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes","volume":"21","author":"Sonmez","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB23","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/archneur.1993.00540060030012","article-title":"Serum lipid levels during carbamazepine medication. A prospective study","volume":"50","author":"Isoj\u00e4rvi","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB24","first-page":"785","article-title":"Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or Phenytoin","volume":"27","author":"Pita-Calandre","year":"1998","journal-title":"Rev Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0920-1211(01)00288-1","article-title":"Antiepileptic drugs as independent predictors of plasma total homocysteine levels","volume":"47","author":"Apeland","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0025-7125(16)30179-1","article-title":"Secondary causes of hyperlipidemia","volume":"78","author":"Stone","year":"1994","journal-title":"Med Clin North Am"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB27","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/01.wnl.0000188819.45330.90","article-title":"Hyponatremia from oxcarbazepine and carbamazepine","volume":"65","author":"Dong","year":"2005","journal-title":"Neurology"},{"issue":"Suppl. 4","key":"10.1111\/j.1600-0404.2008.01146.x-BIB28","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/WNL.67.12_suppl_4.S23","article-title":"Optimizing therapy of seizures in patients with endocrine disorders","volume":"67","author":"Steinhoff","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1474-4422(03)00483-6","article-title":"Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00007691-199302000-00007","article-title":"Influence of single and repeated doses of oxcarbazepine on the pharmacokinetic profile of felodipine","volume":"15","author":"Zaccara","year":"1993","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"Perucca","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0074-7742(06)81015-9","article-title":"Risk and predictability of drug interactions in the elderly","volume":"81","author":"Levy","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB33","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.seizure.2007.12.003","article-title":"Central Nervous system adverse effects of new antiepileptic drugs. A meta-analysis of placebo-controlled studies","volume":"17","author":"Zaccara","year":"2008","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2165\/00002512-200320110-00001","article-title":"Seizures in elderly patients with dementia, Epidemiology and management","volume":"20","author":"Mendez","year":"2003","journal-title":"Drugs Ageing"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB36","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1212\/WNL.36.9.1226","article-title":"Seizures and myoclonus in patients with Alzheimer\u2019s disease","volume":"36","author":"Hauser","year":"1986","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB37","doi-asserted-by":"crossref","first-page":"178S","DOI":"10.1592\/phco.20.12.178S.35251","article-title":"Management of seizures in the elderly","volume":"20","author":"Rowan","year":"2000","journal-title":"Pharamcotherapy"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB38","first-page":"258","article-title":"Effect of seizures on progression of dementia of the Alzheimer type","volume":"6","author":"Volicer","year":"1995","journal-title":"Dementia"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB39","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1468-1331.2007.01907.x","article-title":"Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study","volume":"14","author":"Belcastro","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1176\/ajp.155.1.54","article-title":"Efficacy and tolerability of carbamazepine for agitation and aggression in dementia","volume":"155","author":"Tariot","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB41","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2165\/00002512-200320140-00003","article-title":"Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation","volume":"20","author":"Moretti","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB42","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00019442-200307000-00006","article-title":"Valproate therapy for agitation in dementia: open-label extension of a double-blind trial","volume":"11","author":"Porsteinsson","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/1098-2779(2000)6:4<309::AID-MRDD10>3.0.CO;2-I","article-title":"Treatment of epilepsy in the multiply handicapped","volume":"6","author":"Pellock","year":"2000","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"Suppl. 4","key":"10.1111\/j.1600-0404.2008.01146.x-BIB44","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1212\/WNL.67.12_suppl_4.S52","article-title":"Optimizing therapy of seizures in children and adolescents with developmental disorders","volume":"67","author":"Smith","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB45","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.yebeh.2005.07.006","article-title":"A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life","volume":"7","author":"Kerr","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1059-1311(00)90474-6","article-title":"A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy","volume":"10","author":"Crawford","year":"2001","journal-title":"Seizure"},{"issue":"Suppl. 1","key":"10.1111\/j.1600-0404.2008.01146.x-BIB47","first-page":"57","article-title":"Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability","volume":"42","author":"Mikati","year":"1998","journal-title":"J Intellect Disabil Res"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB48","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/08830738060210051401","article-title":"Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation","volume":"21","author":"McKee","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB49","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.seizure.2005.08.002","article-title":"Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany","volume":"14","author":"Opp","year":"2005","journal-title":"Seizure"},{"issue":"Suppl. 1","key":"10.1111\/j.1600-0404.2008.01146.x-BIB50","first-page":"41","article-title":"Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability","volume":"42","author":"Gaily","year":"1998","journal-title":"J Intellect Disabil Res"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2788.2005.00637.x","article-title":"Topiramate in long-term treatment of epilepsy in the intellectually disabled","volume":"49","author":"Arvio","year":"2005","journal-title":"J Intellect Disabil Res"},{"issue":"Suppl. 1","key":"10.1111\/j.1600-0404.2008.01146.x-BIB52","first-page":"68","article-title":"Long-term effects of zonisamide in the treatment of epilepsy in children with intellectual disability","volume":"42","author":"Iinuma","year":"1998","journal-title":"J Intellect Disabil Res"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0404.2006.00705.x","article-title":"Comparison of efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?","volume":"114","author":"Zaccara","year":"2006","journal-title":"Acta Neurol Scand"},{"issue":"Suppl. 4","key":"10.1111\/j.1600-0404.2008.01146.x-BIB54","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1212\/WNL.67.12_suppl_4.S49","article-title":"Optimizing therapy of seizures in children and adolescents with ADHD","volume":"67","author":"Aldenkamp","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1469-8749.2003.tb00859.x","article-title":"ADHD and epilepsy in childhood","volume":"45","author":"Dunn","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mds.870080104","article-title":"Phenytoin and dyskinesias: a report of two cases and review of the literature","volume":"8","author":"Harrison","year":"1993","journal-title":"Mov Disord"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB57","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1742-1241.2007.01519.x","article-title":"Clinical assessment and treatment of ADHD in children","volume":"61","author":"Smoot","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yebeh.2007.08.001","article-title":"Attention-deficit\/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment","volume":"12","author":"Torres","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB59","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1474-4422(05)70172-1","article-title":"Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study","volume":"4","author":"Olafsson","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB60","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","article-title":"Epilepsy in patients with brain tumors: epidemiology, mechanisms, and management","volume":"6","author":"Van Breemen","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB61","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/jnnp.2006.106211","article-title":"Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment","volume":"78","author":"Singh","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB62","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","article-title":"Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommitee of the American Academy of Neurology","volume":"54","author":"Glantz","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB63","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004424.pub2","article-title":"Antiepileptic drugs for preventing seizures in people with brain tumours","author":"Tremont-Lukats","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB64","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.cco.0000127720.17558.38","article-title":"Management of epileptic seizures","volume":"16","author":"Hildebrand","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB65","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archneur.1995.00540310091021","article-title":"The course of seizure disorders in patients with malignant gliomas","volume":"52","author":"Moots","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB66","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/0470846356.ch12","article-title":"Drug resistance in epilepsy: human epilepsy","volume":"243","author":"Sisodiya","year":"2002","journal-title":"Novartis Found Symp"},{"issue":"Suppl. 4","key":"10.1111\/j.1600-0404.2008.01146.x-BIB67","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.67.12_suppl_4.S10","article-title":"Optimizing therapy of seizures in patients with brain tumors","volume":"67","author":"Vecht","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB68","first-page":"391","article-title":"Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long?","volume":"28","author":"Wick","year":"2005","journal-title":"Onkologie"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11060-005-9070-4","article-title":"Retrospective analysis of the efficacy and tolerability of Levetiracetam in brain tumour patients","volume":"78","author":"Newton","year":"2006","journal-title":"J Neurooncol"},{"issue":"Suppl. 7","key":"10.1111\/j.1600-0404.2008.01146.x-BIB70","first-page":"297","article-title":"Use of Levetiracetam in patients with brain tumours","volume":"43","author":"Siddiqui","year":"2002","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB71","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1059-1311(03)00096-7","article-title":"Levetiracetam preliminary experience in patients with primary brain tumours","volume":"12","author":"Wagner","year":"2003","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-006-9162-9","article-title":"Levetiracetam therapy in patients with brain tumour and epilepsy","volume":"80","author":"Maschio","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB73","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1017\/S0317167100038853","article-title":"add-on gabapentin for refractory seizures in patients with brain tumours","volume":"23","author":"Perry","year":"1996","journal-title":"Can J Neurol Sci"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB74","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11060-007-9430-3","article-title":"Outcome and tolerability of topiramate in brain tumor associated epilepsy","volume":"86","author":"Maschio","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB75","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/028418699431898","article-title":"Stevens-Johnson syndrome in patients on phenytoin and cranial radiotherapy","volume":"38","author":"Khafaga","year":"1999","journal-title":"Acta Oncol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB76","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1592\/phco.19.3.223.30917","article-title":"Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies","volume":"19","author":"Micali","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB77","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1212\/WNL.67.12_suppl_4.S14","article-title":"Optimizing therapy of seizures in neurosurgery","volume":"67","author":"Michelucci","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB78","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(03)00435-6","article-title":"Interactions between antiepileptic and chemotherapeutic agents","volume":"2","author":"Vecht","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","article-title":"P450 enzyme-inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy","volume":"72","author":"Oberndorfer","year":"2005","journal-title":"J Neurooncol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB80","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/j.1875-9114.1991.tb04300.x","article-title":"Interaction of dexamethasone with phenytoin","volume":"11","author":"Lackner","year":"1991","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB81","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0404.108.s180.3.x","article-title":"Epilepsy and comorbidity: infections and antimicrobials usage in relation to epilepsy management","volume":"108","author":"Sander","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB82","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1474-4422(04)00963-9","article-title":"Epidemiology and aetiology of epilepsy in sub-Saharan Africa","volume":"4","author":"Preux","year":"2005","journal-title":"Lancet Neurol"},{"issue":"Suppl. 4","key":"10.1111\/j.1600-0404.2008.01146.x-BIB83","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1212\/WNL.67.12_suppl_4.S19","article-title":"Optimizing therapy of seizures in patients with HIV and cysticercosis","volume":"67","author":"Bhigjee","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB84","first-page":"934","article-title":"Association of human herpesvirus-6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","volume":"157","author":"Tohiama","year":"2007","journal-title":"Clin Lab Invest"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB85","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivation","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB86","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2133.2006.07332.x","article-title":"Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome","volume":"155","author":"Seishima","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB87","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1345\/aph.19014","article-title":"The use of valproic acid in HIV positive patients","volume":"33","author":"Jennings","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB88","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/17843286.1999.11754213","article-title":"How epileptogenic are the recent antibiotics?","volume":"54","author":"Hantson","year":"1999","journal-title":"Acta Clin Belg"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB89","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1345\/aph.19211","article-title":"Carbamazepine-indinavir interaction causes antiretroviral therapy failure","volume":"34","author":"Hugen","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB90","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2165\/00003088-199732030-00003","article-title":"Protease inhibitors in patients with HIV disease: clinically important pharmacokinetic consideration","volume":"32","author":"Barry","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB91","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1474-4422(07)70197-7","article-title":"Epilepsy and HIV - a dangerous combination","volume":"6","year":"2007","unstructured":"91.Epilepsy and HIV - a dangerous combination. Lancet Neurol 2007;6:747.","journal-title":"Lancet Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB92","first-page":"281","volume-title":"Migraine and epilepsy","author":"Anderman","year":"1987"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB93","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1212\/WNL.43.12.2476","article-title":"Migraine related seizures in adults with epilepsy, with EEG correlation","volume":"43","author":"Marks","year":"1993","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB94","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1526-4610.2006.00373.x","article-title":"Relationship between migraine and epilepsy in pediatric age","volume":"46","author":"Piccinelli","year":"2006","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB95","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1007\/s10072-007-0769-1","article-title":"Migraine and epilepsy: clinical and pathophysiological relations","volume":"28","author":"De Simone","year":"2007","journal-title":"Neurol Sci"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB96","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tips.2007.02.005","article-title":"Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms","volume":"28","author":"Calabresi","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB97","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJM199304293281704","article-title":"The occurrence of sleep-disordered breathing among middle-aged adults","volume":"328","author":"Young","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB98","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/01.wnl.0000279334.78298.d5","article-title":"Obstructive sleep apnea is associated with seizure occurrence in older adults with epilepsy","volume":"69","author":"Chihorek","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB99","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000092306","article-title":"Epilepsy and obstructive sleep apnea","volume":"55","author":"Hollinger","year":"2006","journal-title":"Eur Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB100","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1212\/01.wnl.0000279381.88385.e9","article-title":"CPAP. A treatment for epilepsy?","volume":"69","author":"Benbadis","year":"2007","journal-title":"Neurology"},{"issue":"Suppl. 4","key":"10.1111\/j.1600-0404.2008.01146.x-BIB101","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1212\/WNL.67.12_suppl_4.S45","article-title":"Seizures and substance abuse: treatment considerations","volume":"67","author":"Brust","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB102","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00023210-200519100-00005","article-title":"Recent advances in the development of treatments for alcohol and cocaine dependence","volume":"19","author":"Johnson","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB103","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.addbeh.2004.06.014","article-title":"Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?","volume":"29","author":"Johnson","year":"2004","journal-title":"Addict Behav"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB104","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpsyc.61.9.905","article-title":"Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals","volume":"61","author":"Johnson","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00023210-200519010-00002","article-title":"Novel approaches to the treatment of cocaine addition","volume":"19","author":"Sofuoglu","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB106","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1046\/j.1360-0443.2003.00544.x","article-title":"Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomised clinical study","volume":"98","author":"Gonzales","year":"2003","journal-title":"Addiction"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB107","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1528-1157.1999.tb00772.x","article-title":"Risk of epilepsy in patients with multiple sclerosis: a population-based study in Iceland","volume":"40","author":"Olafsson","year":"1999","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB108","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1528-1157.2003.09203.x","article-title":"Epilepsy and multiple sclerosis in Sicily: a population-based study","volume":"44","author":"Nicoletti","year":"2003","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB109","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1528-1167.2008.01565.x","article-title":"Seizures in multiple sclerosis","volume":"49","author":"Koch","year":"2008","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB110","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/14737175.6.4.575","article-title":"Epileptogenic drugs: a systematic review","volume":"6","author":"Ruffmann","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB111","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-2007-1019128","article-title":"Current evidence and therapeutic strategies for multiple sclerosis","volume":"28","author":"Wingerchuk","year":"2008","journal-title":"Semin Neurol"},{"key":"10.1111\/j.1600-0404.2008.01146.x-BIB112","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.wnf.0000159956.87511.67","article-title":"Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy","volume":"28","author":"Otoul","year":"2005","journal-title":"Clin Neuropharmacol"},{"issue":"Suppl. 4","key":"10.1111\/j.1600-0404.2008.01146.x-BIB113","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1212\/WNL.67.12_suppl_4.S28","article-title":"Optimizing therapy of seizures in patients with renal or hepatic dysfunction","volume":"67","author":"Lacerda","year":"2006","journal-title":"Neurology"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2008.01146.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2008.01146.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T22:41:26Z","timestamp":1739140886000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2008.01146.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2008.01146.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"type":"print","value":"0001-6314"},{"type":"electronic","value":"1600-0404"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}